500 patients67,039 observations150 daysLIVE

Patient P-03488

Synthetic patientONX-7 · Day 144 · 45–54 · M · baseline S03Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S03

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Nutritional resilience+12
  • Toxicity-9
  • Treatment adherence+5
  • Inflammatory activity-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    6.2/10
    improving · +0.3 vs previous 14 d
    Stress level
    Daily log
    3.6/10
    stable · +0.0 vs previous 14 d
    Pessimism score
    Daily log
    2.6/10
    improving · -0.3 vs previous 14 d
    Sleep quality
    Wearable
    60.7/100
    improving · +8.5 vs previous 14 d
    Libido
    Daily log
    5.3/10
    stable · -0.1 vs previous 14 d
    HRV
    Wearable
    70.6 ms
    stable · +1.3 vs previous 14 d
    Toxicity
    Blood
    10.2/100
    worsening · +3.3 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 87 from the failing basin, 6 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +8.1
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -4 next day
    Main detractors to watch
    • Enterobacteriaceae elevated
      hidden · steering -7.4
    • Lactose
      perturbation · steering -6
    • Alcohol
      perturbation · steering -4.5
    • Poor-sleep week
      perturbation · steering -3
    • Lactose
      detractor · GI +3.3 next day
    • Alcohol
      detractor · GI +2.9 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4supporter · 95%
    • Lactose
      +3.3detractor · 95%
    • Alcohol
      +2.9detractor · 72%
    • Caffeine
      +1.7no signal · 48%
    • Dietary fat load
      +1.6no signal · 42%
    • Histamine load
      -0.4no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
      DNA
      Fictional pharmacogenomic panel
      • CYP2D6 Intermediate metabolizer
        Expected exposure
      Microbiome
      Shannon diversity 4.5 · butyrate capacity 57/100
      • Akkermansia muciniphilaNormal
      • Faecalibacterium prausnitziiNormal
      • Bacteroides fragilisNormal
      • Bifidobacterium longumLow
      • EnterobacteriaceaeHigh
      Wearable, last 14 days
      daily evolution fed into the runtime
      HRV
      67 ms
      Sleep
      6.4 h
      Steps
      9,789
      Resting HR
      62 bpm
      Daily log: GI score 21, nutritional resilience 71, adherence 96.

      What this patient sees in NostraAI

      The content that steers the trajectory: what to eat, what to do, what to take.

      Open companion preview
      What to eat
      • Keep meals regular; three to four moderate portions spaced through the day
      • Include a cooked vegetable portion with each main meal
      • Keep fibre steady; no new sources this week
      • Avoid known triggers for now: fried or oily food, dairy, alcohol
      What to do
      • Log the daily check-in; one line is enough
      • Keep the current walking rhythm
      • Keep the sleep window steady
      • Keep hydration steady: small amounts through the day rather than large volumes at once
      What to take
      • Take the scheduled dose as agreed with your care team
      • No additional supplements this week
      • Fictional demo item: continue vitamin D as before

      284 biologically similar trajectories

      Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

      PatientSimilarityBaselineInterventionOutcomeResponse today
      P-0326135%S17100
      P-0329136%S1998
      P-0315235%S1798
      P-0312644%S0197
      P-0328329%S0396
      P-0314136%S0295
      P-0300235%S2093
      P-0337034%S0793
      P-0343933%S0692
      P-0335839%S1592
      P-0304831%S1991
      P-0333331%S14SC-12improved91